Search research articles
Contact Us
Filters
Showing results (131-140 of 244) with videos related to
Page
of 25
Sort By:
European Heart Journal
|
December 1, 1996
Secondary preventive potential of lipid-lowering drugs. The Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT)
U de Faire, C G Ericsson, L Grip, et al.
Metabolism: Clinical and Experimental
|
November 1, 1996
High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease
P Tornvall, F Karpe, A Proudler, et al.
Journal of Internal Medicine
|
December 3, 2003
Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men
J Skogsberg, A D McMahon, F Karpe, et al.
International Journal of Molecular Medicine
|
June 14, 2000
Characterization of the human peroxisome proliferator activated receptor delta gene and its expression
J Skogsberg, K Kannisto, L Roshani, et al.
Annals of Medicine
|
October 1, 1992
DNA polymorphism studies. Approaches to elucidating multifactorial ischaemic heart disease: the apo B gene as an example
S E Humphries, A Dunning, C F Xu, et al.
Journal of Lipid Research
|
February 13, 2001
Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides
F Karpe, S Boquist, R Tang, et al.
Diabetes
|
June 26, 2001
Transcriptional regulation of plasminogen activator inhibitor type 1 gene by insulin: insights into the signaling pathway
C Banfi, P Eriksson, G Giandomenico, et al.
British Heart Journal
|
August 1, 1995
Long-term prognostic significance of M mode echocardiography in young men after myocardial infarction
S V Eriksson, K Caidahl, A Hamsten, et al.
The Journal of Biological Chemistry
|
May 31, 1996
Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression
S Ye, P Eriksson, A Hamsten, et al.
Lancet (London, England)
|
March 30, 1996
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients
C G Ericsson, A Hamsten, J Nilsson, et al.
Page
of 25
Search research articles
Search
Showing results (131-140 of 244) with videos related to
Sort By:
Page
of 25
European Heart Journal
|
December 1, 1996
Secondary preventive potential of lipid-lowering drugs. The Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT)
U de Faire, C G Ericsson, L Grip, et al.
Metabolism: Clinical and Experimental
|
November 1, 1996
High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease
P Tornvall, F Karpe, A Proudler, et al.
Journal of Internal Medicine
|
December 3, 2003
Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men
J Skogsberg, A D McMahon, F Karpe, et al.
International Journal of Molecular Medicine
|
June 14, 2000
Characterization of the human peroxisome proliferator activated receptor delta gene and its expression
J Skogsberg, K Kannisto, L Roshani, et al.
Annals of Medicine
|
October 1, 1992
DNA polymorphism studies. Approaches to elucidating multifactorial ischaemic heart disease: the apo B gene as an example
S E Humphries, A Dunning, C F Xu, et al.
Journal of Lipid Research
|
February 13, 2001
Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides
F Karpe, S Boquist, R Tang, et al.
Diabetes
|
June 26, 2001
Transcriptional regulation of plasminogen activator inhibitor type 1 gene by insulin: insights into the signaling pathway
C Banfi, P Eriksson, G Giandomenico, et al.
British Heart Journal
|
August 1, 1995
Long-term prognostic significance of M mode echocardiography in young men after myocardial infarction
S V Eriksson, K Caidahl, A Hamsten, et al.
The Journal of Biological Chemistry
|
May 31, 1996
Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression
S Ye, P Eriksson, A Hamsten, et al.
Lancet (London, England)
|
March 30, 1996
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients
C G Ericsson, A Hamsten, J Nilsson, et al.
Page
of 25